Author

M. Mendenhall

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:virus· 1

Frequent Co-Authors

J. Julander· 2 shared A. Javer· 1 shared B. Liang· 1 shared C. Chen· 1 shared G. Wei· 1 shared H. Michail· 1 shared H. Peng· 1 shared J. J. Baldwin· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Julander

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals

W. Fitzsimmons, T. L. Hartman, M. Mendenhall, C. Chen

The paper evaluates FK1706, a non-immunosuppressive FKBP ligand, in vitro against SARS-CoV-2 alone and in combination with remdesivir, showing synergistic activity.

bioRxiv · Feb 3, 2022 · PreprintPharmacology & Toxicology

In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays

S. P. Tucker, S. Goodall, P. Molloy, J. Julander, M. Mendenhall, P. Friedland

This study evaluates the in vitro efficacy of 0.5% povidone iodine nasal spray against SARS-CoV-2, showing rapid inactivation of culturable virus but not PCR-detectable RNA.

bioRxiv · Jan 31, 2021 · PreprintMicrobiology

In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations

B. Liang, X. Yuan, G. Wei, W. Wang, M. Zhang, H. Peng, A. Javer, M. Mendenhall, J. Julander, S. Huang, H. Michail, Y. Lu, Q. Zhu, J. J. Baldwin

This study evaluates the virucidal activity and safety of Povidone-iodine in-situ gel formulations against SARS-CoV-2 in vitro and in vivo.

bioRxiv · May 18, 2020 · PreprintMicrobiology